# Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery.

> **NCT01818115** · NA · COMPLETED · sponsor: **Ivantis, Inc.** · enrollment: 100 (actual)

## Conditions studied

- Primary Open Angle Glaucoma
- Glaucoma, Open Angle, Pseudo-exfoliative
- Cataract Unilateral Pending Extraction

## Interventions

- **DEVICE:** Hydrus Implant
- **PROCEDURE:** IOL placement

## Key facts

- **NCT ID:** NCT01818115
- **Lead sponsor:** Ivantis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818115, "Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01818115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*